A Prospective Analysis of the HOMA Model: The Mexico City Diabetes Study

  • Steven M Haffner
    Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio San Antonio, Texas
  • Clicerio Gonzalez
    Centra de Estudios en Diabetes, American British Cowdray Hospital Mexico City, Mexico
  • Heikki Miettinen
    Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio San Antonio, Texas
  • Esmarie Kennedy
    Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio San Antonio, Texas
  • Michael P Stern
    Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio San Antonio, Texas

抄録

<jats:sec> <jats:title>OBJECTIVE</jats:title> <jats:p>Both insulin resistance (IR) and decreased insulin secretion have been shown to predict the development of NIDDM. However, methods to assess insulin sensitivity and secretion are complicated and expensive to apply in epidemiological studies. The homeostasis model assessment (HOMA) has been suggested as a method to assess IR and secretion from the fasting glucose and insulin concentrations.</jats:p> </jats:sec> <jats:sec> <jats:title>RESEARCH DESIGN AND METHODS</jats:title> <jats:p>We applied the HOMA model in the 3.5-year follow-up of the Mexico City Diabetes Study.</jats:p> </jats:sec> <jats:sec> <jats:title>RESULTS</jats:title> <jats:p>Out of 1,449 subjects, 97 developed diabetes. When modeled separately insulin resistance but not insulin secretion predicted NIDDM. However, when both variables were entered into the same regression model, both increased IR and decreased β-cell function significantly predicted NIDDM.</jats:p> </jats:sec> <jats:sec> <jats:title>CONCLUSIONS</jats:title> <jats:p>We conclude that the HOMA provides a useful model to assess ²-cell function in epidemiological studies and that it is important to take into account the degree of IR in assessing insulin secretion.</jats:p> </jats:sec>

収録刊行物

  • Diabetes Care

    Diabetes Care 19 (10), 1138-1141, 1996-10-01

    American Diabetes Association

被引用文献 (36)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ